1. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. 

2. The information contained in our website or corporate profile should be viewed as commercial advertisement and is not intended to be investment advice. The Market Observer is not provided to any particular individual with a view toward their individual circumstances. 

3. The information contained in The Market Observer is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them. 

4. The Market Observer has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies’ profiled based solely on information contained in The Market Observer. Individuals should assume that all information contained in the The Market Observer about profiled companies is not trustworthy unless verified by their own independent research. 

5. Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing. 

6. The Market Observer is a service of Straight Edge Marketing Inc., a financial marketing firm that has been compensated by the companies profiled. All direct and third-party compensation received has been disclosed within each individual profile in accordance with section 17(b) of the Securities Act of 1933. Specifically, Straight Edge Marketing Inc. has been paid Fifty Thousand Dollars from The Marketing Connection, Fifty Thousand Dollars from Immix Biopharma Inc., Seventy-Five Thousand Dollars from SLS Group, and an additional media budget of Three Hundred Thirty-Six Thousand Dollars from Immix Biopharma for Profiling the company starting in October 2023 and is ongoing. Compensation numbers will be updated accordingly. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies.

7. Straight Edge Marketing Inc., and/or its affiliates will hold, buy, and sell securities in the companies profiled. This constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. 

8. Information contained in The Market Observer will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. 

9. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable. 

10. We encourage you to invest carefully and read investment information available at the websites of the Securities and Exchange Commission at https://www.sec.gov/ and the Financial Industry Regulatory Authority (“FINRA”) at https://www.finra.org./#/.